This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

K. Lance Gould, MD; Dean Ornish, MD; Larry Scherwitz, PhD; Shirley Brown, MD; R. Patterson Edens, PhD; Mary Jane Hess, RN; Nizar Mullani; Leonard Bolomey; Frank Dobbs, PhD; William T. Armstrong, MD; Terri Merritt, MS; Thomas Ports, MD; Stephen Sparler, MA; James Billings, PhD

JAMA. 1995;274(11):894-901.

Abstract
Objective.
—To quantify changes in size and severity of myocardial perfusion abnormalities by positron emission tomography (PET) in patients with coronary artery disease after 5 years of risk factor modification.

Design.
—Randomized controlled trial.

Setting.
—Outpatient community setting.

Intervention.
—Randomization of patients to risk factor modification consisting of very low-fat vegetarian diet, mild to moderate exercise, stress management, and group support (experimental group, n=20) or to usual care by their own physicians, consisting principally of antianginal therapy (control group, n=15).

Main Outcome Measures.
—Quantitative coronary arteriography and PET at baseline and 5 years after randomization. Automated, objective measures of size and severity of perfusion abnormalities on rest-dipyridamole PET images and of stenosis severity on arteriograms were made by computer algorithms.

Results.
—Size and severity of perfusion abnormalities on dipyridamole PET images decreased (improved) after risk factor modification in the experimental group compared with an increase (worsening) of size and severity in controls. The percentage of left ventricle perfusion abnormalities outside 2.5 SDs of those of normal persons (based on 20 disease-free individuals) on the dipyridamole PET image of normalized counts worsened in controls (mean ±SE, +10.3%±5.6%) and improved in the experimental group (mean ±SE, –5.1 %±4.8%) (P=.02); the percentage of left ventricle with activity less than 60% of the maximum activity on the dipyridamole PET image of normalized counts worsened in controls (+13.5%± 3.8%) and improved in the experimental group (–4.2%±3.8%) (P=.002); and the myocardial quadrant on the PET image with the lowest average activity expressed as a percentage of maximum activity worsened in controls (–8.8%±2.3%) and improved in the experimental group (+4.9%±3.3%)(P=.001 ). The size and severity of perfusion abnormalities on resting PET images were also significantly improved in the experimental group as compared with controls. The relative magnitude of changes in size and severity of PET perfusion abnormalities was comparable to or greater than the magnitude of changes in percent diameter stenosis, absolute stenosis lumen area, or stenosis flow reserve documented by quantitative coronary arteriography.

Conclusions.
—Modest regression of coronary artery stenoses after risk factor modification is associated with decreased size and severity of perfusion abnormalities on rest-dipyridamole PET images. Progression or regression of coronary artery disease can be followed noninvasively by dipyridamole PET reflecting the integrated flow capacity of the entire coronary arterial circulation.

(JAMA. 1995;274:894-901)

Author Affiliations
From the Department of Medicine (Drs Gould, Edens, and Dobbs and Messrs Mullani and Bolomey) and the Positron Diagnostic and Research Center (Ms Hess) of the University of Texas Medical School at Houston; the Preventive Medicine Research Institute, Sausalito, Calif (Drs Ornish, Scherwitz, and Billings, Ms Merritt, and Mr Sparler); California Pacific Medical Center, San Francisco (Drs Ornish and Armstrong); and the University of California at San Francisco (Drs Ornish, Brown, and Ports).

Footnotes
Reprint requests to Division of Cardiology, Room 4.258MSB, 6431 Fannin, University of Texas Medical School at Houston, Houston, TX 77030 (Dr Gould).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Socioeconomic Status and Improvements in Lifestyle, Coronary Risk Factors, and Quality of Life: The Multisite Cardiac Lifestyle Intervention Program
Govil et al.
AJPH 2009;99:1263-1270.
ABSTRACT | FULL TEXT  

Cardiac positron emission tomography.
Bengel et al.
J Am Coll Cardiol 2009;54:1-15.
ABSTRACT | FULL TEXT  

Coronary flow reserve and pharmacologic stress perfusion imaging beginnings and evolution.
Gould
J Am Coll Cardiol Img 2009;2:664-669.
FULL TEXT  

Myocardial Perfusion Reserve in Ischemic Heart Disease
Neglia and L'Abbate
JNM 2009;50:175-177.
FULL TEXT  

Behavioral and Complementary Approaches for the Treatment of Irritable Bowel Syndrome
Wald and Rakel
Nutr Clin Pract 2008;23:284-292.
ABSTRACT | FULL TEXT  

Reducing Radiation Dose in Rest-Stress Cardiac PET/CT by Single Poststress Cine CT for Attenuation Correction: Quantitative Validation
Gould et al.
JNM 2008;49:738-745.
ABSTRACT | FULL TEXT  

Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype
Laughlin et al.
J. Appl. Physiol. 2008;104:588-600.
ABSTRACT | FULL TEXT  

Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections
Gould et al.
JNM 2007;48:1112-1121.
ABSTRACT | FULL TEXT  

New Technology for Noninvasive Evaluation of Coronary Artery Disease
Di Carli and Hachamovitch
Circulation 2007;115:1464-1480.
FULL TEXT  

Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk Factor Analysis Versus PET for Detection of Microvascular Disease
Graf et al.
JNM 2007;48:175-181.
ABSTRACT | FULL TEXT  

Influence of ageing on perioperative cardiac risk in non-cardiac surgery
Bai et al.
Age Ageing 2007;36:68-72.
ABSTRACT | FULL TEXT  

Lower Myocardial Perfusion Reserve Is Associated With Decreased Regional Left Ventricular Function in Asymptomatic Participants of the Multi-Ethnic Study of Atherosclerosis
Rosen et al.
Circulation 2006;114:289-297.
ABSTRACT | FULL TEXT  

Mechanisms of Progression and Regression of Coronary Artery Disease by PET Related to Treatment Intensity and Clinical Events at Long-Term Follow-up
Sdringola et al.
JNM 2006;47:59-67.
ABSTRACT | FULL TEXT  

Influence of Risk Factors on Coronary Flow Reserve in Patients with 1-Vessel Coronary Artery Disease
Vicario et al.
JNM 2005;46:1438-1443.
ABSTRACT | FULL TEXT  

Comparison of Diets for Weight Loss and Heart Disease Risk Reduction
Ornish
JAMA 2005;293:1589-1590.
FULL TEXT  

Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications
Kaufmann and Camici
JNM 2005;46:75-88.
FULL TEXT  

Low-Carbohydrate Diets
Ornish
ANN INTERN MED 2004;141:738-738.
FULL TEXT  

Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: Coronary artery disease regression single photon emission computed tomography monitoring trial
Schwartz et al.
J Am Coll Cardiol 2003;42:600-610.
ABSTRACT | FULL TEXT  

Optimal Diets to Prevent Heart Disease
Masley et al.
JAMA 2003;289:1510-1510.
FULL TEXT  

Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease
Sdringola et al.
J Am Coll Cardiol 2003;41:263-272.
ABSTRACT | FULL TEXT  

In the statin era, how important are intense lifestyle changes?
Parmley
J Am Coll Cardiol 2003;41:273-274.
FULL TEXT  

Anti-Ischemic Therapy and Myocardial Ischemia Shown by Single Photon Emission Computed Tomography Imaging
Auer et al.
Circulation 2001;104 :e151-e152.
FULL TEXT  

Evaluation of the Culprit Plaque and the Physiological Significance of Coronary Atherosclerotic Narrowings
Kern and Meier
Circulation 2001;103:3142-3149.
FULL TEXT  

CT and Arteriography in the Evaluation of Indirect Myocardial Revascularization with a Free-Muscle Transplant: Initial Experience
Krämer et al.
Radiology 2000;216:123-127.
ABSTRACT | FULL TEXT  

Frequency and Clinical Implications of Fluid Dynamically Significant Diffuse Coronary Artery Disease Manifest as Graded, Longitudinal, Base-to-Apex Myocardial Perfusion Abnormalities by Noninvasive Positron Emission Tomography
Gould et al.
Circulation 2000;101:1931-1939.
ABSTRACT | FULL TEXT  

Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Tests for Silent and Inducible Ischemia : Writing Group II
Smith et al.
Circulation 2000;101 :e12-e16.
FULL TEXT  

Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy
Yokoyama et al.
Circulation 1999;100:117-122.
ABSTRACT | FULL TEXT  

Intensive Lifestyle Changes for Reversal of Coronary Heart Disease
Ornish et al.
JAMA 1998;280:2001-2007.
ABSTRACT | FULL TEXT  

Very Low Fat Diets
Lichtenstein and Van Horn
Circulation 1998;98:935-939.
FULL TEXT  

More on Low-Fat Diets
Thompson and Ornish
NEJM 1998;338:1623-1624.
FULL TEXT  

Serum Lipids After a Low-Fat Diet
Ornish and Knopp
JAMA 1998;279:1345-1346.
FULL TEXT  

Low-Fat Diets
Ornish et al.
NEJM 1998;338:127-129.
FULL TEXT  

Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects
Hasdai et al.
Circulation 1997;96:3390-3395.
ABSTRACT | FULL TEXT  

Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention : Role of Physical Exercise
Niebauer et al.
Circulation 1997;96:2534-2541.
ABSTRACT | FULL TEXT  

Functional Evaluation of Lipid-Lowering Therapy by Pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)
Aengevaeren et al.
Circulation 1997;96:429-435.
ABSTRACT | FULL TEXT  

Dietary Guidelines for Healthy American Adults: A Statement for Health Professionals From the Nutrition Committee, American Heart Association
Krauss et al.
Circulation 1996;94:1795-1800.
FULL TEXT  

Very Low-Fat Diets for Coronary Heart Disease: Perhaps, But Which One?
Siguel et al.
JAMA 1996;275:1402-1402.
ABSTRACT  

Atherosclerosis and Risk Factor Modification: Does It Really Make a Difference?
Corson et al.
PERSPECT VASC SURG ENDOVASC THER 1996;9:75-94.
 

Aggressive Risk Modification Improves Perfusion
Journal Watch Cardiology 1995;1995:13-13.
FULL TEXT